| (210) | Number of the EPO application | 22754752 |
| (220) | Filing date of the EPO application | 2022.07.27 |
| (80) | EPO patent specification publication (B) | EPB nr. 41/2024, 2024.10.09 |
| (110) | EPO patent number | 4214240 |
| (21) | Number of the application | e 2023 0750 |
| (71) | Name(s) of applicant(s), code of the country | AbbVie Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | MCCLUSKEY Andrew J., US;
SCHMIDT PAUSTIAN Amanda M., US;
SEAGAL Jane, US;
WILSBACHER Julie L., US; |
| (73) | Name(s) of owner(s), code of the country | AbbVie Inc., US; |
| (54) | Title of the invention | ANTI-CCR8 ANTIBODIES |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01); A61P 35/00 (2006.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2023.08.31 |
| (30) | Priority | 202163226118 P, 2021.07.27, US |
| (86) | International application | PCT/US2022/074214, 2022.07.27 |
| (87) | International publication | WO 2023/010054, 2023.02.02 |